• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dr Michael Kolodziej Discusses the Role of Commercial Payers in Value-Based Care

Video

Michael Kolodziej, MD, vice president and chief innovation officer at ADVI Health, Inc., weighs in on the role of commercial payers in value-based care.

Michael Kolodziej, MD, vice president and chief innovation officer at ADVI Health, Inc., weighs in on the role of commercial payers in value-based care.

Transcript

Are commercial payers beginning to have a bigger presence in value-based care?

The issue with commercial payers is that they’re very interesting in doing things that are easy for them administratively. I don’t think they’re going to embrace [Oncology Care Model]. It’s just too complicated. It’s just too much work. I believe pathways are going to be—and you can certainly define pathways as value-based care. In fact, there is no definition of value-based care. There’s a broad spectrum of what constitutes value-based care, and pathways clearly exists within that spectrum.

I think payers will all adopt some sort of “value-based care program.” It might not be what the folks at OncoCloud consider value-based care, but it is by the strictest sense of the word a model of care.

Related Videos
Pat Van Burkleo
Jeff Stark, MD, vice president, head of medical immunology, UCB
Robert Groves, MD
Screenshot of Raajit Rampal, MD, PhD
 Laura Ferris, MD, PhD, professor of dermatology, University of Pittsburgh
Dr Padma Sripada, Columbia Internal Medicine
Screenshot of Jennifer Vaughn, MD, in a Zoom video interview
dr amy paller
Shawn Kwatra, MD, dermatologist, John Hopkins University
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.